In addition, a diverse array of recurrent genomic mutations were found in these tumors, including TP53, IDH1, NF1, PTEN, PDGFRA, EGFR and MAPK pathway mutations, with particular mutations being enriched in particular glioblastoma subtypes. This evidence concerns the gene NF1 and glioblastoma.